Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared values into action – every day. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
Many have overlooked the key essence of eConsent because of various interpretations and misconceptions.
This article aims to bring some of the fundamental aspects of eConsent back on track through harmonization while also touching upon its flexibility and value drivers.
Choosing the Consent digital feature(s) for a specific study should be based on a careful assessment of the type of disease, the kind of study, the site(s), and the number of participants. Incorporating more eConsent digital features does not necessarily result in more benefits. It all depends on the value drivers for the participant and investigator.
There is no one size that fits all eConsent models - each disease, each study, each site, and each participant might have different needs. Ultimately, eConsent tools should be flexible, easy to use, and created as paper consent.
Read up on this here to brush up on the eConsent basics and give it the place it deserves!
TCS ADD™ Webinar: Shaping the Future of AI-driven SDTM Harmonization
Automating Third Party Data Transfer Through Digitized Electronic DTA
TCS ADD™ Risk-Based Quality Management Platform
Reimagining Reporting and Visualization During CDM
Integrated ecosystems are key to better patient outcomes.
Talk to our experts